1. Home
  2. PGEN vs MVBF Comparison

PGEN vs MVBF Comparison

Compare PGEN & MVBF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Precigen Inc.

PGEN

Precigen Inc.

HOLD

Current Price

$4.07

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Logo MVB Financial Corp.

MVBF

MVB Financial Corp.

HOLD

Current Price

$26.39

Market Cap

329.1M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
PGEN
MVBF
Founded
1998
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
329.1M
IPO Year
2013
2004

Fundamental Metrics

Financial Performance
Metric
PGEN
MVBF
Price
$4.07
$26.39
Analyst Decision
Buy
Strong Buy
Analyst Count
5
5
Target Price
$8.33
$27.60
AVG Volume (30 Days)
5.3M
28.9K
Earning Date
05-13-2026
04-29-2026
Dividend Yield
N/A
2.58%
EPS Growth
N/A
34.64
EPS
N/A
2.06
Revenue
$230,981,000.00
$3,400,000.00
Revenue This Year
$1,115.92
$1.70
Revenue Next Year
$81.04
$13.59
P/E Ratio
N/A
$12.79
Revenue Growth
N/A
51.92
52 Week Low
$1.23
$15.59
52 Week High
$5.47
$29.59

Technical Indicators

Market Signals
Indicator
PGEN
MVBF
Relative Strength Index (RSI) 56.65 52.49
Support Level $4.02 $24.95
Resistance Level $4.44 $26.36
Average True Range (ATR) 0.30 0.73
MACD 0.11 0.21
Stochastic Oscillator 79.23 74.76

Price Performance

Historical Comparison
PGEN
MVBF

About PGEN Precigen Inc.

Precigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary technology platforms. These platforms support the development of gene programs, delivery through viral, non-viral, and microbe-based approaches, and control of gene expression for safety and efficacy. Its key platforms include AdenoVerse immunotherapy and UltraCAR-T, supported by the UltraPorator device for rapid and cost-effective manufacturing. Its clinical pipeline includes PRGN-2009, PRGN-3005, PRGN-3006, and PRGN-3007. Its reportable segments are Biopharmaceuticals and Exemplar.

About MVBF MVB Financial Corp.

MVB Financial Corp is a bank holding company. The company provides Personal banking, Business banking, and Fintech solutions. The group has identified three reportable segments: CoRe Banking, Mortgage Banking, and Financial Holding Company. The majority of ts revenue generated from the CoRe Banking segment, which includes the Fintech division, represents banking products and services offered to customers by the Bank, loans, and deposit accounts. Revenue from banking activities consists of interest earned on loans and investment securities and service charges on deposit accounts.

Share on Social Networks: